Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (202)	8/30/1999 10:21:00 PM
From: kendall harmon	Read Replies (1) of 427

CLTR--Ginsberg reiterated a strong buy Princeton, New Jersey, Aug. 30 (Bloomberg Data) -- Coulter Pharmaceutical Inc. (CLTR US) was reiterated ''strong buy'' by analyst Peter L. Ginsberg at U.S. Bancorp Piper Jaffray. The near-term price target is $36 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next